Summary of Study ST000663
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000466. The data can be accessed directly via it's Project DOI: 10.21228/M8TG86 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000663 |
Study Title | Metabolic Syndrome Plasma Lipidomics |
Study Type | MS analysis |
Study Summary | Plasma of metabolic syndrome patients will be checked for lipidomic profiles |
Institute | University of Michigan |
Department | Biomedical Research Core Facilities |
Laboratory | Metabolomics core |
Last Name | Kachman |
First Name | Maureen |
Address | 6300 Brehm Tower, 1000 Wall Street, Ann Arbor, MI 48105-5714 |
mkachman@med.umich.edu | |
Phone | (734) 232-8175 |
Submit Date | 2017-06-05 |
Num Groups | 5 |
Total Subjects | 20 |
Raw Data Available | Yes |
Raw Data File Type(s) | wiff |
Analysis Type Detail | LC-MS |
Release Date | 2017-12-06 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000466 |
Project DOI: | doi: 10.21228/M8TG86 |
Project Title: | Metabolic Syndrome Studies |
Project Type: | MS analysis |
Project Summary: | Plasma lipidomics |
Institute: | University of Michigan |
Department: | UMich Internal Medicine |
Laboratory: | Pennathur Lab |
Last Name: | Pennathur |
First Name: | Subramaniam |
Address: | University Michigan, 2900 Huron Parkway, Ann Arbor, MI 48105 |
Email: | spennath@umich.edu |
Phone: | 734 615 5757 |
Subject:
Subject ID: | SU000686 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | control | visit |
---|---|---|---|
SA038157 | S00015580 | Control | Control |
SA038158 | S00015581 | Control | Control |
SA038159 | S00015578 | Control | Control |
SA038160 | S00015572 | Control | Control |
SA038161 | S00015579 | Control | Control |
SA038162 | S00015574 | Control | Control |
SA038163 | S00015573 | Control | Control |
SA038164 | S00015577 | Control | Control |
SA038165 | S00015575 | Control | Control |
SA038166 | S00015576 | Control | Control |
SA038167 | S00015606 | Metabolic syndrom | MS Visit 1 |
SA038168 | S00015591 | Metabolic syndrom | MS Visit 1 |
SA038169 | S00015603 | Metabolic syndrom | MS Visit 1 |
SA038170 | S00015588 | Metabolic syndrom | MS Visit 1 |
SA038171 | S00015582 | Metabolic syndrom | MS Visit 1 |
SA038172 | S00015597 | Metabolic syndrom | MS Visit 1 |
SA038173 | S00015585 | Metabolic syndrom | MS Visit 1 |
SA038174 | S00015600 | Metabolic syndrom | MS Visit 1 |
SA038175 | S00015609 | Metabolic syndrom | MS Visit 1 |
SA038176 | S00015594 | Metabolic syndrom | MS Visit 1 |
SA038177 | S00015601 | Metabolic syndrom | MS Visit 3 |
SA038178 | S00015610 | Metabolic syndrom | MS Visit 3 |
SA038179 | S00015598 | Metabolic syndrom | MS Visit 3 |
SA038180 | S00015607 | Metabolic syndrom | MS Visit 3 |
SA038181 | S00015604 | Metabolic syndrom | MS Visit 3 |
SA038182 | S00015592 | Metabolic syndrom | MS Visit 3 |
SA038183 | S00015589 | Metabolic syndrom | MS Visit 3 |
SA038184 | S00015586 | Metabolic syndrom | MS Visit 3 |
SA038185 | S00015595 | Metabolic syndrom | MS Visit 3 |
SA038186 | S00015583 | Metabolic syndrom | MS Visit 3 |
SA038187 | S00015608 | Metabolic syndrom | MS Visit 4 |
SA038188 | S00015611 | Metabolic syndrom | MS Visit 4 |
SA038189 | S00015587 | Metabolic syndrom | MS Visit 4 |
SA038190 | S00015584 | Metabolic syndrom | MS Visit 4 |
SA038191 | S00015605 | Metabolic syndrom | MS Visit 4 |
SA038192 | S00015596 | Metabolic syndrom | MS Visit 4 |
SA038193 | S00015602 | Metabolic syndrom | MS Visit 4 |
SA038194 | S00015593 | Metabolic syndrom | MS Visit 4 |
SA038195 | S00015590 | Metabolic syndrom | MS Visit 4 |
SA038196 | S00015599 | Metabolic syndrom | MS Visit 4 |
Showing results 1 to 40 of 40 |
Collection:
Collection ID: | CO000680 |
Collection Summary: | - |
Sample Type: | Blood |
Treatment:
Treatment ID: | TR000700 |
Treatment Summary: | - |
Sample Preparation:
Sampleprep ID: | SP000693 |
Sampleprep Summary: | - |
Sampleprep Protocol Filename: | A004_-_Shotgun_Lipidomics.pdf |
Combined analysis:
Analysis ID | AN001012 | AN001013 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Shimadzu CTO-20A Nexera X2 | Shimadzu CTO-20A Nexera X2 |
Column | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) |
MS Type | ESI | ESI |
MS instrument type | Triple TOF | Triple TOF |
MS instrument name | ABI Sciex 5600+ TripleTOF | ABI Sciex 5600+ TripleTOF |
Ion Mode | NEGATIVE | POSITIVE |
Units | peak area normalized | peak area normalized |
Chromatography:
Chromatography ID: | CH000726 |
Instrument Name: | Shimadzu CTO-20A Nexera X2 |
Column Name: | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) |
Column Temperature: | 55 |
Flow Rate: | 0.400uL/min |
Solvent A: | 40% acetonitrile/60% water; 10 mM ammonium acetate |
Solvent B: | 10% acetonitrile/5% water/85% isopropanol; 10 mM ammonium acetate |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS000907 |
Analysis ID: | AN001012 |
Instrument Name: | ABI Sciex 5600+ TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
Ion Mode: | NEGATIVE |
Analysis Protocol File: | A004_-_Shotgun_Lipidomics.pdf |
MS ID: | MS000908 |
Analysis ID: | AN001013 |
Instrument Name: | ABI Sciex 5600+ TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
Ion Mode: | POSITIVE |
Analysis Protocol File: | A004_-_Shotgun_Lipidomics.pdf |